Partial nephrectomy as a model for uremic cardiomyopathy in the mouse

Area of Science:

• Nephrology
• Cardiology
• Translational Medicine

Background:

• Uremic cardiomyopathy is a significant complication in chronic kidney disease (CKD) patients.
• Existing animal models, like rats, exhibit uremic cardiomyopathy, but a versatile mouse model is needed.
• Mice offer extensive genetic tools for studying disease mechanisms.

Purpose of the Study:

• To establish and characterize a mouse model of uremic cardiomyopathy.
• To assess if a 5/6 nephrectomy in mice recapitulates human and rat uremic cardiomyopathy phenotypes.
• To provide a genetically tractable model for investigating CKD-related cardiac pathology.

Main Methods:

• A 5/6 nephrectomy was performed on mice using electrocautery and surgical resection.
• Hypertension and circulating marinobufagenin levels were monitored.
• Cardiac function was assessed using invasive physiological measurements and tissue Doppler imaging.
• Cardiac morphology and molecular markers of fibrosis and calcium handling were analyzed.

Main Results:

• The 5/6 nephrectomy induced sustained hypertension and elevated marinobufagenin.
• Impaired left ventricular relaxation was observed at 4 weeks, with diastolic dysfunction evident at 6 weeks.
• Cardiac hypertrophy, progressive fibrosis, and altered sarcoplasmic reticulum calcium ATPase expression were noted.
• Increased expression of collagen-1, fibronectin, and vimentin indicated fibrotic changes.

Conclusions:

• Partial nephrectomy in mice successfully establishes a model of uremic cardiomyopathy.
• This murine model shares key phenotypic features with human and rat uremic cardiomyopathy.
• The model provides a valuable platform for studying the pathogenesis and potential treatments of CKD-associated heart disease.